PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1076969
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1076969
The global Otoacoustic Emissions (OAE) Screening Systems market is estimated to be worth $490.7 million in 2021. Otoacoustic Emissions (OAE) Screening Systems market is expected to expand at an 7.4% CAGR during the forecast period.
Otoacoustic emission (OAE) examinations are used to detect cochlear conditions, particularly hair cell function. This information can be used to screen hearing, especially in neonates, infants, and people with developmental disabilities, estimate hearing sensitivity, and distinguish between the sensory and neural components of sensorineural hearing loss. Because no behavioral response is necessary, information can be acquired from individuals who are sleeping or even unconscious.
The normal cochlea not only receives sound but also makes OAEs, which are low-intensity sounds. The cochlea is the organ that produces these sounds. The otoacoustic emission products are available in a variety of sizes and configurations, including portable and display models that show sound strength over a range of frequencies. Transient otoacoustic emissions and distortion product otoacoustic emissions are two types of otoacoustic emissions. In TOAEs, the sound is emitted for a short time and covers a wide range of frequencies to test newborns for hearing status and cochlear functions, and DPOAEs are used for detailing two different frequencies to test cochlear along with damage and ototoxicity.
One of the major factors projected to drive the growth and demand for hearing screening diagnostic devices is the rapid rise in noise pollution, which leads to hearing loss. Furthermore, the global Otoacoustic Emissions (OAE) Screening Systems market is expected to grow due to an increase in the geriatric population and increased awareness due to the implementation of various government programs and endorsements for advanced hearing screening diagnostics devices. Hearing loss is becoming more common as a result of ototoxic drugs, hearing ailments, hereditary abnormalities, and birth difficulties, all of which are expected to boost market growth. Furthermore, in countries with a large number of hearing loss cases, early detection and intervention programs are essential and are predicted to be important contributors to the market for Otoacoustic Emissions (OAE) Screening Systems. Rapid technology improvements, rising healthcare expenditures, and the high prevalence of hearing problems and losses are likely to provide substantial potential possibilities for the Otoacoustic Emissions (OAE) Screening Systems market.
Otoacoustic Emissions (OAE) Screening Systems Market is segmented By Product, End User, and Geography. Based on end-user, the pediatric segment is expected to register a high CAGR of 7.6%. The OAE test is the most common screening procedure performed on newborns shortly after birth. It's a small, portable piece of equipment. In the child's ear, a tiny earpiece with a speaker and microphone is implanted. If the cochlea is working properly, a click sound is played, and the earpiece picks up the answer. OAE tests assist in the detection of hearing disorders at a preventive stage in infants. In 2019, more than 98% of newborns in the U.S. were screened for hearing loss, out of which almost 6,000 U.S. infants born were identified with a permanent hearing loss. Otoacoustic emission is a great screening method for identifying a newborn's hearing ability fast. The use of sophisticated technology in the creation of Otoacoustic emission has made it much more effective for testing hearing impairments at various stages. The market's understanding of Otoacoustic emission for hearing problem testing is growing, as is the rate of change.
Players compete and collaborate to achieve a significant market share in this highly fragmented market. Companies are adopting strategies to gain a significant share of the market. Product approvals, agreements, partnerships, and collaboration are important strategies adopted by the players.
For instance, In October 2019, Demant launched a new hearing screening device, easyScreen BERAphone, at the 64th International Congress of Hearing Aid Acousticians in Germany. Moreover, in January 2018, the company launched a new handheld hearing screener for newborns, GSI Novus.
The scope of this report covers the market by its major segments, which include as follows: